𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma

✍ Scribed by Lei Zhang; Jian-Qiang Cai; Jian-Jun Zhao; Xin-Yu Bi; Xiao-Gang Tan; Tao Yan; Cong Li; Ping Zhao

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
97 KB
Volume
101
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Impact of systemic inflammation on outco
Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma
✍ Dhanwant Gomez; Gareth Morris-Stiff; Giles J. Toogood; J. Peter A. Lodge; K. Raj πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 99 KB πŸ‘ 1 views

## Abstract ## Aims To analyse the results and prognostic factors affecting disease‐free and overall survival following potentially curative resection for intrahepatic cholangiocarcinoma (IHCC). ## Methods Patients undergoing resection for IHCC from January 1996 to December 2006 were included. D

Impact of hepatitis B virus surface prot
Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection
✍ Mira El Chaar; Daniel Candotti; R. Anthony Crowther; Jean Pierre Allain πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 294 KB πŸ‘ 1 views

Genotype D occult hepatitis B virus (HBV) infections (OBIs) have a high frequency of amino acid substitutions in the major hydrophilic region of the small surface protein (S protein). This possibly reflects an escape mutation mechanism to evade detection by the host immune system. Mutations may also

Outcome of patients with hepatitis B vir
Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation
✍ Norah A. Terrault; Jonathan T. Carter; Laurie Carlson; Michelle E. Roland; Peter πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 138 KB πŸ‘ 2 views

The outcome of patients with hepatitis B virus (HBV) and human immunodeficiency virus (HIV) referred for liver transplantation (LT) is unknown. A high frequency of lamivudine-resistant (LAM-R) HBV infection may increase the risk of liver-related death pre-transplantation and prophylaxis failure post